Lumentum Holdings Inc.: Form 10-Q for the period ended Jan 1, 2022
Filed with the SEC on Feb 3, 2022 and accepted by EDGAR at Feb 3, 2022, 14:31 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-01-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 3 months2021-10-03 to 2022-01-01 | $207.5m | us-gaap:GrossProfit |
| Gross profit | 6 months2021-07-04 to 2022-01-01 | $439.7m | us-gaap:GrossProfit |
| Research and development | 3 months2021-10-03 to 2022-01-01 | $53.2m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2021-07-04 to 2022-01-01 | $107.3m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2021-10-03 to 2022-01-01 | $69.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2021-07-04 to 2022-01-01 | $132.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2021-10-03 to 2022-01-01 | $85.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2021-07-04 to 2022-01-01 | $201.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-10-03 to 2022-01-01 | $17.1m | us-gaap:InterestExpense |
| Interest expense | 6 months2021-07-04 to 2022-01-01 | $34.0m | us-gaap:InterestExpense |
| Income tax | 3 months2021-10-03 to 2022-01-01 | $12.4m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2021-07-04 to 2022-01-01 | $30.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-10-03 to 2022-01-01 | $56.7m | us-gaap:NetIncomeLoss |
| Net income | 6 months2021-07-04 to 2022-01-01 | $138.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-10-03 to 2022-01-01 | $0.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2021-07-04 to 2022-01-01 | $1.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-10-03 to 2022-01-01 | $0.78 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2021-07-04 to 2022-01-01 | $1.91 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-10-03 to 2022-01-01 | 75,300,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2021-07-04 to 2022-01-01 | 75,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2021-07-04 to 2022-01-01 | $268.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2021-07-04 to 2022-01-01 | $44.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2021-07-04 to 2022-01-01 | $126.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-01-01 | $552.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-01-01 | $2.54bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-01-01 | $3.62bn | us-gaap:Assets |
| Current liabilities | At period end2022-01-01 | $656.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-01-01 | $1.59bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-01-01 | $1.53bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2022-01-01 | $2.02bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-22-001745. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.